scholarly journals Red Wine Grape Pomace Attenuates Atherosclerosis and Myocardial Damage and Increases Survival in Association with Improved Plasma Antioxidant Activity in a Murine Model of Lethal Ischemic Heart Disease

Nutrients ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 2135 ◽  
Author(s):  
Katherine Rivera ◽  
Francisca Salas-Pérez ◽  
Guadalupe Echeverría ◽  
Inés Urquiaga ◽  
Sara Dicenta ◽  
...  
Keyword(s):  
Antioxidant Activity ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Red Wine ◽  
Myocardial Damage ◽  
Grape Pomace ◽  
Ischemic Heart ◽  
Wine Grape ◽  
Plasma Antioxidant ◽  
The Impact

A healthy dietary pattern and high quality nutrient intake reduce atherosclerotic cardiovascular disease risk. Red wine grape pomace (RWGP)—a rich natural source of dietary fiber and antioxidants—appears to be a potential functional food ingredient. The impact of a dietary supplementation with RWGP flour was evaluated in atherogenic diet-fed SR-B1 KO/ApoER61h/h mice, a model of lethal ischemic heart disease. SR-B1 KO/ApoER61h/h mice were fed with atherogenic (high fat, cholesterol, and cholic acid, HFC) diet supplemented with: (a) 20% chow (HFC-Control), (b) 20% RWGP flour (HFC-RWGP), or (c) 10% chow/10% oat fiber (HFC-Fiber); and survival time was evaluated. In addition, SR-B1 KO/ApoER61h/h mice were fed for 7 or 14 days with HFC-Control or HFC-RWGP diets and plasma lipid levels, inflammation, oxidative damage, and antioxidant activity were measured. Atherosclerosis and myocardial damage were assessed by histology and magnetic resonance imaging, respectively. Supplementation with RWGP reduced premature death, changed TNF-α and IL-10 levels, and increased plasma antioxidant activity. Moreover, decreased atheromatous aortic and brachiocephalic plaque sizes and attenuated myocardial infarction and dysfunction were also observed. These results suggest that RWGP flour intake may be used as a non-pharmacological therapeutic approach, contributing to decreased progression of atherosclerosis, reduced coronary heart disease, and improved cardiovascular outcomes.

Intake of Red Wine Grape Pomace Decreased Atherosclerosis, Attenuated Myocardial Damage and Increased Survival in a Murine Model of Lethal Coronary Heart Disease

2018 ◽  
Vol 32 ◽  
pp. 137
Author(s):  
Francisca Salas-Pérez ◽  
Katherine Rivera ◽  
Guadalupe Echeverría ◽  
Inés Urquiaga ◽  
Sara Dicenta ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Murine Model ◽  
Red Wine ◽  
Myocardial Damage ◽  
Grape Pomace ◽  
Wine Grape

scholarly journals HEART RATE VARIABILITY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME, PRIMARY SNORING AND ISCHEMIC HEART DISEASE

2018 ◽  
Vol 15 (3) ◽  
pp. 286-292
Author(s):  
A. Bulgak ◽  
E. Tarasik
Keyword(s):  
Obstructive Sleep Apnea ◽  
Heart Disease ◽  
Sleep Apnea ◽  
Ischemic Heart Disease ◽  
Sinus Node ◽  
Sleep Apnea Syndrome ◽  
Ischemic Heart ◽  
Primary Snoring ◽  
Obstructive Sleep ◽  
The Impact

The purpose of our study is to assess the impact of cardiac arrhythmias, heart rhythm variability in patients with ischemic heart disease, obstructive sleep apnea and primary snoring. 65 patients at an age of 40–68 years with ischemic heart disease, obstructive sleep apnea and primary snoring were researched.Obstructive sleep apnea and primary snoring lead to an increase in the sympathetic and parasympathetic activity of the autonomic nervous system on the sinus node in patients with ischemic heart disease, obstructive sleep apnea and primary snoring.

The impact of G5665T polymorphism of endothelin-1 gene, on endothelin-1 levels and left ventricular function in ischemic heart disease

2013 ◽  
Vol 168 (2) ◽  
pp. 1568-1569 ◽  
Author(s):  
Dimitris Tousoulis ◽  
Eirini Toli ◽  
Antigoni Miliou ◽  
Nikolaos Papageorgiou ◽  
Charalambos Antoniades ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Left Ventricular Function ◽  
Ventricular Function ◽  
Left Ventricular ◽  
Ischemic Heart ◽  
Endothelin 1 ◽  
The Impact

Symptoms of fatigue and depression in ischemic heart disease are driven by personality characteristics rather than disease stage: a comparison of CAD and CHF patients

2008 ◽  
Vol 15 (5) ◽  
pp. 583-588 ◽  
Author(s):  
Otto R.F. Smith ◽  
Susanne S. Pedersen ◽  
Ron T. Van Domburg ◽  
Johan Denollet
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Early Stage ◽  
Multivariable Analysis ◽  
Type D Personality ◽  
Ischemic Heart ◽  
Disease Stage ◽  
Type D ◽  
The Impact

Background Symptoms of fatigue and depression are prevalent across stages of ischemic heart disease (IHD). We examined (i) the effect of both the IHD stage and type-D personality on fatigue and depressive symptoms at 12-month follow-up, and (ii) whether the effect of type-D personality on these symptoms is moderated by IHD stage. Methods Two different samples of patients were included to represent IHD stage: 401 percutaneous coronary intervention patients (early-stage IHD) and 105 ischemic chronic heart failure patients (end-stage IHD) completed the DS14 Type-D Scale at baseline. Logistic regression analysis was used to examine the impact of IHD stage and type-D personality on fatigue and depression at follow-up. Results Disease stage was neither associated with symptoms of fatigue ( P = 0.99) nor depression ( P = 0.29) at 12 months. In contrast, type-D personality was shown to predict both symptoms of fatigue [odds ratio (OR) = 2.96; 95% confidence interval (CI): 1.92–4.58, P < 0.001] and depression (OR = 4.91; 95% CI: 3.16–7.65, P < 0.001) at follow-up; the effect of type-D personality on these symptoms was not moderated by disease stage. In multivariable analysis, type-D remained a significant predictor of symptoms of fatigue (OR = 3.14; 95% CI: 1.98–4.99, P < 0.001) and depression (OR = 5.90; 95% CI: 3.60–9.67, P < 0.001), also after controlling for symptom levels at baseline. Conclusion Type-D personality but not disease stage predicted symptoms of fatigue and depression at 12-month follow-up.

scholarly journals The Impact of the Introduction of Clinical Recommendations on Cardiology in the USA and Russia Federetionon Mortality from Ischemic Heart Diseas

2018 ◽  
Vol 17 (4) ◽  
pp. 30-37
Author(s):  
A. A. Gerasimov
Keyword(s):  
United States ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Russian Federation ◽  
Clinical Guidelines ◽  
The United States ◽  
Ischemic Heart ◽  
The Russian Federation ◽  
The Impact

1 million 824 thousand people died in the Russian Federation in 2017, including 457 thousand from ischemic heart disease (IHD). IHD caused more than a quarter of deaths in Russia. Goal. The article analyzes the impact of implementation of clinical guidelines in cardiology in medical practice in the United States and the Russian Federation on the dynamics of mortality from ischemic heart disease and its outcomes in different age groups. Results. The results showed that the implementation of clinical guidelines (CG) increased the rate of mortality reduction from coronary heart diseases in Russia and the United States, which may indicate a positive impact CG on the quality of medical care. Conclusions. A higher level of mortality from coronary heart disease in Russia compared to the United States may be due to less commitment of doctors to the principles of therapy and diagnosis of various forms of coronary heart disease, set out in clinical guidelines.

scholarly journals Falls among patients with hypertension - preliminary study

2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
N Swiatoniowska-Lonc ◽  
E Jaciow ◽  
J Polanski ◽  
B Jankowska-Polanska
Keyword(s):  
Heart Failure ◽  
Heart Disease ◽  
High Risk ◽  
Ischemic Heart Disease ◽  
Beta Blockers ◽  
The Elderly ◽  
Ischemic Heart ◽  
Risk Of Falling ◽  
Risk Of Falls ◽  
The Impact

Abstract Funding Acknowledgements Type of funding sources: None. Background. Falls among the elderly are a major cause of injury, significant disability and premature death. Hypotension is a potential risk factor for falls in older adults, especially patients with hypertension (HTN) taking antihypertensive drugs. Furthermore, the cardiovascular benefit of treatment of hypertension in older patients is clear, findings from observational studies have raised concerns that antihypertensive therapies in the elderly might also induce adverse effects, including injurious falls.  In spite of the large number of issues related to this topic, the analysis of the causes of falls is insufficient. The aim of the study was to assess the frequency of falls and the impact of selected variables on the occurrence of risk of falls among patients with HTN. Material and methods. 100 patients, including 55 women, with HTN (mean age 69.4 ± 3.29 years) were enrolled into the study. The Tinetti test was used to assess the risk of falls. Sociodemographic and clinical data were obtained from the hospital register. Results. 89% of patients had a high risk of falls and 11% were prone to falls. The average number of falls during the last year in the study group was 1.86 ± 2.82 and in 30% of cases the fall was the cause of hospitalization. Single-factor analysis of the influence of selected variables on the risk of falls showed that higher values of SBP (-0.27; p = 0.007), DBP (-0.279; p = 0.005) and younger age of patients decrease the risk of falls (-0.273; p = 0.006). The linear regression model showed that independent predictors increasing the risk of falling are: use of diuretics (β=4.192; p &lt; 0.001), co-occurrence of ischemic heart disease (β=4.669; p = 0. 007) and co-occurrence of heart failure (β=3.494; p = 0.016), and predictors reducing the risk of falling patients with hypertension are: the use of beta-blockers (β= -4.033; p = 0.013) and higher DBP value (β= -0.123; p = 0.016). Conclusions. Patients with HTN have a high risk of falling. Independent determinants increasing the risk of falling patients with HTN are the use of diuretics and the co-occurrence of ischemic heart disease or heart failure, while beta-blockers and a higher DBP value are factors reducing the risk of falling. Fall risk assessment and implementation of fall prevention should be carried out in everyday practice.

scholarly journals Effects of Peanut (Arachis Hypogaea L.) and Its Combination with Propranolol in Isoproterenol Induced Myocardial Damage in Rats

2016 ◽  
Vol 11 (2) ◽  
pp. 74-79 ◽  
Author(s):  
Farah Naz ◽  
Nasim Jahan ◽  
Nayma Sultana ◽  
Mohammad Hayatun Nabi
Keyword(s):  
Body Weight ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Myocardial Damage ◽  
Ischemic Heart ◽  
Albino Rats ◽  
Initial Body Weight ◽  
Final Body Weight ◽  
Bonferroni Test ◽  
Wistar Albino Rats

Background: Ischemic heart disease is the interruption of blood supply to the heart causes several biochemical alterations which may lead to cardiac dysfunction and ultimately cell death. Medicinal plants and plant based foods such as peanut (Arachishypogaea L.) have received great attention for their salutary effects and potential to treat many aspects of ischemic heart disease due to their antioxidant property.Objective: To observe the effects of peanut (Arachishypogaea L.) and its combination with propranolol in isoproterenol induced myocardial damage in rats.Method: This experimental study was carried out in the Department of Physiology, Sir Salimullah Medical College (SSMC), Dhaka in 2012. For this purpose, 20 Wistar albino rats, age 85 to 100 days, weighing 120 to 150g (initial body weight) were included in the peanut treated group.They were sub-divided into CT-P (Cardiotoxic group with isoproterenol after peanut treatment) and CT-C (Cardiotoxic group with isoproterenol after combined treatment of peanut and propranolol). Age and weight matched 30 Wistar albino rats without any peanut supplementation were taken and sub-divided into three sub-groups, BC (Baseline control), CT (Cardiotoxic group with isoproterenol) and CT-PRO (Cardiotoxic group with isoproterenol after propranolol treatment). Each sub-group consisted of 10 rats. After taking final body weight all the rats were sacrificed on 22nd day. Blood was collected from heart & supernatant serum was preserved in deep freeze until analysis. For assessment of myocardial damage, some cardiac biomarker enzymes, like serum CK-MB & LDH were estimated by using immunoassay method. The statistical analysis was done by one way ANOVA and Bonferroni test as applicable.Result: In this study, percent change from initial body weight to final body weight was significantly (p<0.01) lower both in CT-P and CT-C as compared to that of BC. Again, the mean serum CK-MB and LDH levels were significantly (p<0.01) higher in CT, CT-PRO, CT-P & CT-C in comparison to that of BC. On the other hand, the serum CK-MB and LDH levels were lower in CT-PRO, CT-P and CT-C when compared to that of CT though the differences were statistically significant (p<0.01, p<0.05) in case of CT-PRO and CT-C but not significant in case of CTP. Again, the values were also significantly lower in CT-C (p<0.01,p<0.05) as compared to that of CTP.Conclusion: The present study revealed that peanut can lower serum CK-MB & LDH levels towards normal in isoproterenol induced myocardial damaged rats. However, the combined therapy of peanut with propranolol showed synergistic effect on lowering serum CK-MB & LDH levels.Bangladesh Soc Physiol. 2016, December; 11(2): 74-79

Abstract 241: Evaluation of the Parameters of the Euro Qol- 5 D Questionnaire Among Patients With Ischemic Heart Disease With Normal and Elevated BMI

2015 ◽  
Vol 8 (suppl_2) ◽  
Author(s):  
Cyril James ◽  
Shreya Ohri ◽  
Snezhana Tisheva ◽  
Dilyana Yakova ◽  
Martin Hristov ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Self Care ◽  
Ischemic Heart ◽  
Usual Activity ◽  
Female Ratio ◽  
Coronary Syndrome ◽  
The Impact

Objective: The epidemic of obesity and obesity related morbidities is an important public health challenge, and is paralleled by growing incidence of metabolic syndrome which acts as a strong and significant risk factor for Ischemic heart disease and other atherosclerotic vascular events. The psychological impact of these chronic conditions can be very disturbing. In practical terms the functional effect of an illness and its therapy upon a patient, as perceived by the patient - could be estimated by introducing the quantitative approach of - Health Related Quality of Life (HRQoL). Aim: The aim of this study is to evaluate the impact of obesity on quality of life of patients with ischemic heart disease. Design and method: Questionnaire based cross sectional study was conducted among patients with established Coronary Artery Disease admitted in the Department of Cardiology in the University Hospital. 520 patients who were admitted in the Cardiology Department between 1st of January 2012 and 30th June 2014 with acute coronary syndrome or coronary angiographic or Electrocardiography evidence of ischemic heart disease were included in the study, stratified by age, sex and BMI ( normal weight 18.5 - 24.9, overweight 25 - 29.9, obese 30 and above). EuroQol - 5D (EQ-5D) was administered in the patients during their hospital stay. EQ-5D comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The height, weight and basic laboratory parameters were recorded. Results: Mean age of the participants was 65.1± 10.6 years. Male female ratio was 0.76. The distribution of patients in BMI groups was 36.8%/ 24.4%/ 38.8%. Statistically significant differences between BMI groups were seen in Usual activity (p=0.005) and self-care (p=0.044) dimensions of EQ-5D-5L with poorest outcome in the obese. We have found significantly positive correlation between BMI and usual activities (R=0.234, p=0.001) and between age and anxiety (R= 0.366 p=0.045). Mean BMI of patients with extreme problems with extreme problems with usual activities is significantly greater than those with lower intensity of problems. Patients with extreme anxiety tend to have higher mean age. Conclusion: Our study revealed that Ischemic heart disease patients with obesity had impaired QoL in terms of health, mobility, usual activity, discomfort and anxiety. Hence non-obese ischemic heart disease patients had a better sense of overall wellbeing.

Sign in / Sign up

Export Citation Format

Share Document